Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Well discuss this during your consultation
Clearance items are final sale and cannot be returned or exchanged
By proceeding with any purchase, you acknowledge that you have carefully read and fully understand this disclaimer, accept all risks associated with research chemical handling, and agree to use our products only for legitimate research purposes in compliance with all applicable laws
For Alzheimer disease, the current FDA-approved treatments include donepezil, rivastigmine, galantamine, memantine, and more recently lecanemab and donanemab (anti-amyloid antibodies with modest clinical effects)
US$ 26.31
US$ 22.58
US$ 25.29
US$ 24.18
US$ 25.58
US$ 24.40
US$ 28.66
US$ 22.94
US$ 22.82
